Hip replacement
Conditions
Interventions
Group B:20 ml of 0.665% bupivacaine liposome was injected into the hip joint through a pericapsular approach guided by ultrasound
Group L:20 ml of 0.5% ropivacaine was injected into the iliac fascia nerve block at the anterior superior spine plane under ultrasound guidance
Sponsors
Lu'an Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Grade ASA? ~ ? grade, BMI18.5-30 kg/m2;Male or female, age >=65 years old
Exclusion criteria
Exclusion criteria: (1) Refusing to participate in the study; (2) Allergic to the investigational drug; (3) For patients contraindoed with regional anesthesia (abnormal coagulation time and platelet count, infection in the puncture area, peripheral neuropathy, etc.); (4) long-term use of analgesic sedative drugs; (5) Patients with serious systemic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesic effect VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Additional analgesic medication;Hospitalization time and hospitalization expenses ;Anesthesia complication; | — |
Countries
China
Contacts
Public ContactRenhu Li
Lu'an Hospital of Anhui Medical University
Outcome results
None listed